Want to see AIQUY full AI Analyst Report?
AIQUY Stock Chart & Stats
$40.38
-$0.31(-0.95%)
At close: 4:00 PM EST
$40.38
-$0.31(-0.95%)
Day’s Range― - ―
52-Week Range$33.03 - $41.20
Previous CloseN/A
Volume351.08K
Average Volume (3M)84.03K
Market Cap
$128.30B
Enterprise Value$131.94K
Total Cash (Recent Filing)$3.96B
Total Debt (Recent Filing)$13.60B
Price to Earnings (P/E)29.1
Beta0.27
Next Earnings
Jul 28, 2026EPS Estimate
0.71Next Dividend Ex-DateN/A
Dividend Yield1.78%
Share Statistics
EPS (TTM)1.21
Shares Outstanding3,190,807,400
10 Day Avg. Volume106,421
30 Day Avg. Volume84,026
Financial Highlights & Ratios
PEG Ratio11.86
Price to Book (P/B)3.20
Price to Sales (P/S)3.24
P/FCF Ratio34.75
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.49
Revenue Forecast (FY)$32.39B
Bulls Say, Bears Say
Bulls Say
Margin Expansion & GuidanceSustained margin improvement is driven by efficiency programs, cost savings and operational leverage, with management targeting a cumulative +560bps by 2027. That structural margin uplift supports durable earnings power, higher recurring ROCE and greater internal funding for investments.
Consistent Strong Cash GenerationReliable, high operating cash flow and record 2025 cash provide long-term funding for CapEx, backlog delivery, dividends and strategic M&A. Strong cash conversion underpins financial flexibility and reduces dependence on external financing for multi-year projects and hydrogen investments.
Robust Investment Backlog & PipelineA large, visible backlog and record 12‑month pipeline provide multi-quarter revenue visibility and contracted project work. This supports medium-term growth execution, leverages the asset base and technology capabilities, and helps smooth cyclicality in merchant volumes.
Bears Say
Three-year Revenue DeclineMulti-year top-line weakness limits leverage from improved margins and constrains long-term growth optionality. Persistent revenue declines raise questions about end-market demand recovery, increase reliance on cost programs for EPS growth, and may cap scale benefits of fixed assets.
Weakened Free Cash Flow ConversionLower FCF and weak FCF-to-net-income conversion indicate heavier reinvestment, capex or working-capital drag. This reduces distributable cash and makes dividend growth, de‑risking balance sheet or aggressive M&A more dependent on restoring conversion rather than on headline cash generation alone.
Rising Debt / Acquisition LeverageHigher debt and a noted leverage uptick, plus pro-forma leverage impacts from recent bolt-on deals, reduce financial flexibility. Increased leverage narrows room for cyclical shocks, raises refinancing sensitivity and could limit pace of discretionary investments if cash conversion lags.
Air Liquide News
AIQUY FAQ
What was Air Liquide’s price range in the past 12 months?
Air Liquide lowest stock price was $33.03 and its highest was $41.20 in the past 12 months.
What is Air Liquide’s market cap?
Air Liquide’s market cap is $128.30B.
When is Air Liquide’s upcoming earnings report date?
Air Liquide’s upcoming earnings report date is Jul 28, 2026 which is in 7 days.
How were Air Liquide’s earnings last quarter?
Air Liquide released its earnings results on Feb 20, 2026. The company reported $0.676 earnings per share for the quarter, missing the consensus estimate of $0.705 by -$0.029.
Is Air Liquide overvalued?
According to Wall Street analysts Air Liquide’s price is currently Overvalued.
Does Air Liquide pay dividends?
Air Liquide pays a Annually dividend of $0.779 which represents an annual dividend yield of 1.78%. See more information on Air Liquide dividends here
What is Air Liquide’s EPS estimate?
Air Liquide’s EPS estimate is 0.71.
How many shares outstanding does Air Liquide have?
Air Liquide has 3,190,807,400 shares outstanding.
What happened to Air Liquide’s price movement after its last earnings report?
Air Liquide reported an EPS of $0.676 in its last earnings report, missing expectations of $0.705. Following the earnings report the stock price went up 5.019%.
Which hedge fund is a major shareholder of Air Liquide?
Currently, no hedge funds are holding shares in AIQUY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Air Liquide Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 6.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.4%
Last 30 Days ▲ 12.4%
Last 30 Days ▲ 12.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
11.65%
12-Months-Change
Fundamentals
Return on Equity
1.78%
Trailing 12-Months
Asset Growth
13.52%
Trailing 12-Months
Company Description
Air Liquide
L'Air Liquide S.A., established in Paris, France, in 1902, is a worldwide leader in providing essential industrial and medical gases, cutting-edge technologies, and specialized services. Its operations extend across Europe, the Americas, Asia Pacific, the Middle East, and Africa. Through its Gas & Services division, the company delivers fundamental industrial gases, including oxygen, nitrogen, argon, hydrogen, and carbon monoxide, to heavy industries such as metallurgy, chemical processing, refining, and energy. This segment also provides a broad array of gases, application-specific equipment, and associated support to diverse sectors like materials and energy, automotive, manufacturing, food and pharmaceuticals, technology and research, as well as independent businesses and retailers. In the healthcare domain, L'Air Liquide furnishes medical gases, hygiene products, vital equipment, and care services to hospitals and for patients receiving home care. Additionally, it manufactures and distributes specialized healthcare ingredients essential for the cosmetics, pharmaceutical, and vaccine markets. Crucially, it supplies gases, materials, and services integral to the production of semiconductors, flat panel displays, and photovoltaic cells. The Engineering & Construction arm focuses on the design, development, and construction of industrial gas production facilities, both for internal use and for external clients. It further specializes in designing and building plants tailored for various energy sectors, encompassing traditional, renewable, and alternative sources. Finally, the Global Markets & Technologies segment is dedicated to developing and deploying advanced technological solutions, including specialized molecules, equipment, and services. These innovations primarily support the global energy transition, with a strong focus on sustainable transport, energy generation, and waste valorization. This segment also engages in deep technological ventures, aiding endeavors in space exploration, aerospace, and large-scale scientific initiatives. Committed to fostering clean mobility, it invests in biomethane production facilities and establishes distribution networks for natural bio-gas for vehicles and hydrogen for transport. Furthermore, it manages biomethane production specifically for the maritime industry and supplies gases to offshore oil and gas platforms, wind turbines, and for cryogenic shipping operations.
Technical Analysis
Ownership Overview
―
Insiders
0.03% Mutual Funds
<0.01% Other Institutional Investors
99.96% Public Companies and
Individual Investors










